pantoprazole has been researched along with histamine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bakke, I; Brenna, E; Qvigstad, G; Sandvik, AK; Waldum, HL | 1 |
| Bakke, I; Chen, D; Håkanson, R; Tostrup-Skogaker, N; Waldum, HL; Zhao, CM | 1 |
| Chen, Y; Hou, Y; Li, H; Li, S; Lin, J; Liu, T; Ma, Y; Wang, Y; Yang, H; Zhang, X; Zhang, Y; Zhou, L; Zhou, X | 1 |
3 other study(ies) available for pantoprazole and histamine
| Article | Year |
|---|---|
Gastrin has a specific proliferative effect on the rat enterochromaffin-like cell, but not on the parietal cell: a study by elutriation centrifugation.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Benzimidazoles; Cell Division; Cell Fractionation; Centrifugation; Cytoplasmic Granules; Enterochromaffin Cells; Enzyme Inhibitors; Female; Gastric Mucosa; Gastrins; Histamine; Hyperplasia; Microscopy, Electron; Omeprazole; Pantoprazole; Parietal Cells, Gastric; Rats; Rats, Sprague-Dawley; Sulfoxides | 2000 |
Functionally impaired, hypertrophic ECL cells accumulate vacuoles and lipofuscin bodies. An ultrastructural study of ECL cells isolated from hypergastrinemic rats.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Benzimidazoles; Cell Division; Cell Size; Enterochromaffin-like Cells; Enzyme Inhibitors; Female; Gastric Acid; Gastric Mucosa; Gastrins; Histamine; Histamine Release; Histidine Decarboxylase; Hypertrophy; Lipofuscin; Microscopy, Electron; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rats; Rats, Sprague-Dawley; Secretory Vesicles; Stomach; Sulfoxides; Time Factors; Vacuoles | 2001 |
Acid suppressants use and risk of atherosclerotic cardiovascular disease in middle-aged and older adults.
Topics: Aged; Antihypertensive Agents; Atherosclerosis; Cardiovascular Diseases; Histamine; Humans; Lansoprazole; Middle Aged; Omeprazole; Pantoprazole; Prospective Studies; Proton Pump Inhibitors; Risk Assessment; Risk Factors | 2022 |